Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Loading Dose Regimens in Obese Patients
NCT02764359Completed
- Sponsor
- CAMC Health System
- Start
- Aug 2016
- Primary completion
- Apr 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vancomycin in Infection and sepsis (2 arms), sponsored by CAMC Health System. Primary endpoint: Time to Attain Therapeutic Vancomycin Concentrations at 20 days. Started Aug 2016; status: completed.
02
Drugs
vancomycin
03
Conditions
Infectionsepsis
Beyond the preview
Go deeper on NCT02764359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02764359.